| Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone H Ismail, Z Shakkour, M Tabet, S Abdelhady, A Kobaisi, R Abedi, ... Antioxidants 9 (10), 943, 2020 | 96 | 2020 |
| Drug repurposing: promises of edaravone target drug in traumatic brain injury Z Shakkour, H Issa, H Ismail, O Ashekyan, KJ Habashy, L Nasrallah, ... Current medicinal chemistry 28 (12), 2369-2391, 2021 | 23 | 2021 |
| Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone. Antioxidants 2020; 9: 943 H Ismail, Z Shakkour, M Tabet, S Abdelhady, A Kobaisi, R Abedi, ... | 7 | |
| An open label pilot study of the safety and tolerability of perampanel in amyotrophic lateral sclerosis M Hotait, HH Ismail, GE Saab, JS Salameh Muscle & Nerve 64 (4), 504-508, 2021 | 5 | 2021 |
| Nonmotor symptoms in amyotrophic lateral sclerosis and their correlation with disease progression N Jaafar, E Malek, H Ismail, J Salameh Journal of Clinical Neuromuscular Disease 23 (1), 1-6, 2021 | 4 | 2021 |
| Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial M Agha, H Ismail, R Sawaya, J Salameh Muscle & Nerve 68 (2), 206-210, 2023 | 2 | 2023 |
| Characteristics of amyotrophic lateral sclerosis in Lebanon-a chart review E Malek, H Ismail, H Doumiati, J Salameh Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (7-8), 614-619, 2020 | 2 | 2020 |
| Efficacy of Apraclonidine in Treating Ptosis Secondary to Myasthenia Gravis (P6-13.001) MK Agha, H Ismail, R Sawaya, J Salameh Neurology 98 (18_supplement), 2431, 2022 | | 2022 |
| Characteristics of Guillain-Barré syndrome in a Lebanese tertiary care center H Ismail, E Malek, L Saroufim, J Salameh Neuromuscular Disorders 31 (8), 765-768, 2021 | | 2021 |
